IBDEI0FK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6867,1,3,0)
 ;;=3^Perichondritis Right External Ear,Unspec
 ;;^UTILITY(U,$J,358.3,6867,1,4,0)
 ;;=4^H61.001
 ;;^UTILITY(U,$J,358.3,6867,2)
 ;;=^5006499
 ;;^UTILITY(U,$J,358.3,6868,0)
 ;;=H61.002^^46^453^5
 ;;^UTILITY(U,$J,358.3,6868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6868,1,3,0)
 ;;=3^Perichondritis Left External Ear,Unspec
 ;;^UTILITY(U,$J,358.3,6868,1,4,0)
 ;;=4^H61.002
 ;;^UTILITY(U,$J,358.3,6868,2)
 ;;=^5006500
 ;;^UTILITY(U,$J,358.3,6869,0)
 ;;=L81.0^^46^453^20
 ;;^UTILITY(U,$J,358.3,6869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6869,1,3,0)
 ;;=3^Postinflammatory Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,6869,1,4,0)
 ;;=4^L81.0
 ;;^UTILITY(U,$J,358.3,6869,2)
 ;;=^5009310
 ;;^UTILITY(U,$J,358.3,6870,0)
 ;;=L81.7^^46^453^14
 ;;^UTILITY(U,$J,358.3,6870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6870,1,3,0)
 ;;=3^Pigmented Purpuric Dermatosis
 ;;^UTILITY(U,$J,358.3,6870,1,4,0)
 ;;=4^L81.7
 ;;^UTILITY(U,$J,358.3,6870,2)
 ;;=^5009317
 ;;^UTILITY(U,$J,358.3,6871,0)
 ;;=L29.8^^46^453^31
 ;;^UTILITY(U,$J,358.3,6871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6871,1,3,0)
 ;;=3^Pruritus NEC
 ;;^UTILITY(U,$J,358.3,6871,1,4,0)
 ;;=4^L29.8
 ;;^UTILITY(U,$J,358.3,6871,2)
 ;;=^5009152
 ;;^UTILITY(U,$J,358.3,6872,0)
 ;;=Z85.828^^46^453^9
 ;;^UTILITY(U,$J,358.3,6872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6872,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,6872,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,6872,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,6873,0)
 ;;=B36.0^^46^453^17
 ;;^UTILITY(U,$J,358.3,6873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6873,1,3,0)
 ;;=3^Pityriasis Versicolor
 ;;^UTILITY(U,$J,358.3,6873,1,4,0)
 ;;=4^B36.0
 ;;^UTILITY(U,$J,358.3,6873,2)
 ;;=^5000608
 ;;^UTILITY(U,$J,358.3,6874,0)
 ;;=Z92.3^^46^453^7
 ;;^UTILITY(U,$J,358.3,6874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6874,1,3,0)
 ;;=3^Personal Hx of Irradiation (Therapeutic)
 ;;^UTILITY(U,$J,358.3,6874,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,6874,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,6875,0)
 ;;=Z91.82^^46^453^10
 ;;^UTILITY(U,$J,358.3,6875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6875,1,3,0)
 ;;=3^Personal Hx of Military Deployment
 ;;^UTILITY(U,$J,358.3,6875,1,4,0)
 ;;=4^Z91.82
 ;;^UTILITY(U,$J,358.3,6875,2)
 ;;=^5063626
 ;;^UTILITY(U,$J,358.3,6876,0)
 ;;=L66.0^^46^453^37
 ;;^UTILITY(U,$J,358.3,6876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6876,1,3,0)
 ;;=3^Pseudopelade
 ;;^UTILITY(U,$J,358.3,6876,1,4,0)
 ;;=4^L66.0
 ;;^UTILITY(U,$J,358.3,6876,2)
 ;;=^191705
 ;;^UTILITY(U,$J,358.3,6877,0)
 ;;=Z85.820^^46^453^8
 ;;^UTILITY(U,$J,358.3,6877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6877,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,6877,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,6877,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,6878,0)
 ;;=Z87.2^^46^453^11
 ;;^UTILITY(U,$J,358.3,6878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6878,1,3,0)
 ;;=3^Personal Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,6878,1,4,0)
 ;;=4^Z87.2
 ;;^UTILITY(U,$J,358.3,6878,2)
 ;;=^5063484
 ;;^UTILITY(U,$J,358.3,6879,0)
 ;;=L08.0^^46^453^42
 ;;^UTILITY(U,$J,358.3,6879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6879,1,3,0)
 ;;=3^Pyoderma
 ;;^UTILITY(U,$J,358.3,6879,1,4,0)
 ;;=4^L08.0
 ;;^UTILITY(U,$J,358.3,6879,2)
 ;;=^5009078
 ;;^UTILITY(U,$J,358.3,6880,0)
 ;;=L73.1^^46^453^36
 ;;^UTILITY(U,$J,358.3,6880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6880,1,3,0)
 ;;=3^Pseudofolliculitis Barbae
 ;;^UTILITY(U,$J,358.3,6880,1,4,0)
 ;;=4^L73.1
 ;;^UTILITY(U,$J,358.3,6880,2)
 ;;=^5009284
